A LOW DOSE GLUCOCORTICOID, LOW DOSE CYCLOPHOSPHAMIDE, RITUXIMAB TREATMENT PROTOCOL AS INDUCTION THERAPY IN ANCA ASSOCIATED VASCULITIS PATIENTS

被引：0
|
作者：
Spanos, Georgios [1 ]
Paschou, Styliani [1 ]
Bakou, Marianna [1 ]
Atalla, Alexandros [1 ]
Bantis, Christos [1 ]
Fragidis, Stylianos [1 ]
Armetzoiou, Livia Karmen [1 ]
Bamichas, Gerasimos [1 ]
机构：
[1] Gen Hosp Thessaloniki G Papanikolaou, Dept Nephrol, Thessaloniki, Greece
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5835
引用
收藏
页码：I405 / I406
页数：2
相关论文
共 50 条
  • [31] Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial
    Furuta, Shunsuke
    Sugiyama, Takao
    Umibe, Takeshi
    Kaneko, Yuko
    Amano, Koichi
    Kurasawa, Kazuhiro
    Nakaomi, Daiki
    Hiraguri, Masaki
    Hanaoka, Hideki
    Sato, Yasunori
    Ikeda, Kei
    Nakajima, Hiroshi
    BMJ OPEN, 2017, 7 (12):
  • [32] Comparison Between Induction with Rituximab and Cyclophosphamide in Treatment of Childhood-Onset ANCA-Associated Vasculitis
    Gagne, Samuel
    Morishita, Kimberly
    Bosman, Else
    Sivaraman, Vidya
    Cabral, David
    Klamer, Brett
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 170 - 172
  • [33] Pharmacological Response of Rituximab Based on Dose Intensity in Maintenance Therapy of ANCA-Associated Vasculitis
    Springer, Jason
    Funk, Ryan
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 854 - 856
  • [34] LONG TERM OUTCOME OF PATIENTS WITH ANCA ASSOCIATED VASCULITIS AND SEVERE RENAL INVOLVEMENT TREATED WITH RITUXIMAB AND LOW-DOSE CONVENTIONAL IMMUNOSUPRESSION
    Marinaki, Smaragdi
    Skalioti, Chrysanthi
    Kapsia, Eleni
    Kalaitzakis, Emmanouil
    Xagas, Efstathios
    Vallianou, Kalliopi
    Boletis, John
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [35] Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Bekker, Pirow
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1535 - 1535
  • [36] Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement A comparative cohort study
    Speer, Claudius
    Altenmueller-Walther, Christine
    Splitthoff, Jan
    Nusshag, Christian
    Kaeble, Florian
    Reichel, Paula
    Morath, Christian
    Zeier, Martin
    Bergner, Raoul
    Schaier, Matthias
    MEDICINE, 2021, 100 (29) : E26733
  • [37] Comparison of Lupus Nephritis Induction Therapy with Cyclophosphamide High Dose Versus Low Dose
    Valim, Juliana
    Lima, Veronica
    Guimardes, Fernanda
    Chaer, Fernanda
    Souza, Branca
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [38] Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
    Vink, Coralien H.
    Wetzels, Jack F. M.
    van de Logt, Anne-Els
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (12): : 3439 - 3445
  • [39] Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis Reply
    Furuta, Shunsuke
    Ikeda, Kei
    Nakajima, Hiroshi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1536 - 1537
  • [40] B cell-driven reduced-dose rituximab as induction therapy for 2 patients with ANCA-associated renal vasculitis: A case series
    Wang, Qinglian
    Wang, Simeng
    Liu, Xiang
    Cheng, Fajuan
    Xu, Ying
    CLINICAL NEPHROLOGY, 2025, 103 (02) : 140 - 147
12345